HAVCR2 and glioblastoma: Inhibiting Gal-9/Tim-3 signaling, either with anti-Tim-3 antibodies or genetic knockdown methods, effectively reduces immunosuppressive TAM polarization and slows tumor proliferation in PTEN-null GBM [48].